| Table 5: | |||
|
Risk
Stratification and Treatment
|
|||
|
Stage
|
Group
A
|
Group
B
|
Group
C
|
| No risk factors; no TOD/ no CCD | At least 1 risk factor, but not including DM; no TOD/ no CCD | TOD/CCD
and/or DM, ± other risk factors |
|
| High-normal | LM | LM | Drug |
| Stage 1 | LM (up to 1 y) | LM (up to 6 mo) | Drug |
| Stage 2 and 3 | Drug | Drug | Drug |
|
TOD=Target
organ damage; CCD=Clinical cardiovascular disease; DM=Diabetes mellitus;
LM=Lifestyle Modification |
|||
|
Copyright
2002 The Cleveland Clinic Foundation
|
Return to Clinical Management of Isolated Systolic Hypertension Chapter